+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 56Days - 84Days
All Genders
Healthy Volunteers
ID07457060

Study Comparing Immunity and Safety of Different Injection Methods for Sabin and Wild Strain Inactivated Poliovirus Vaccines in Infants

Led by Sinovac Biotech Co., Ltd · Updated on 2026-03-09

480

Participants Needed

3

Research Sites

5 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing the immune response and safety of the Sabin strain and wild strain inactivated poliovirus vaccines sIPV and wIPV given by two different injection methods in healthy infants. This phase IV trial involves 480 infants aged 56 to 84 days and aims to assess which vaccination schedule and injection route produce better immunity and safety profiles. The study is randomized and open-label, focusing on immunogenicity and tolerability of sequential vaccination regimens. Participants are randomly assigned into four groups receiving different sequences of three doses of poliovirus vaccine at 28-day intervals, with some receiving the vaccines intramuscularly and others subcutaneously. The four vaccination regimens include combinations of wIPV and sIPV doses. Each group has two-thirds of infants receiving injections into the muscle and one-third receiving injections under the skin. During the study, infants will be observed for immediate reactions for 30 minutes after each vaccine dose, and guardians will record adverse events for 28 days post-vaccination. Blood samples will be collected before the first dose and about 28 days after the final dose to measure antibodies against poliovirus types. Mothers will also provide blood samples or pregnancy test results to screen for infections that could affect the infant. Researchers will track immune response and safety outcomes throughout the trial, which ends in October 2026.

CONDITIONS

Brief Title

Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here